Sreedevi Kodali, MD
Basic profileThe University of Texas Southwestern Medical Center
Sreedevi Kodali is a Dermatology physician affiliated with The University of Texas Southwestern Medical Center. OpenAlex indexes 5 publications with 279 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5013 Heritage Ave Ste 100
Colleyville, TX 760345990
Telephone
817-868-1616Registry record last updated 22 Aug 2013.
Industry payments
20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20255 payments
- UCB, Inc.Program year20253 payments
- Novartis Pharmaceuticals CorporationProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
24.8%Corticosteroid19.3%Triamcinolone Acetonide96%Fluocinolone Acetonide5%Part D<11 patientsPolyene Antifungal2.4%Nystatin100%Part D≥24 patients+ 3 more classes in this area
Anti-infectives
24.4%Tetracycline-class Drug7.2%Doxycycline Hyclate100%Part D≥59 patientsAzole Antifungal6.8%Ketoconazole85%Fluconazole15%Part D<11 patients+ 3 more classes in this area
Cardiovascular
18.3%Arteriolar Vasodilator13.8%Minoxidil100%Part D≥66 patientsCorticosteroid3.6%Fluocinonide100%Part D≥35 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A prospective, randomized, split-face, controlled trial of salicylic acid peels in the treatment of melasma in Latin American women
Journal of the American Academy of Dermatology
2010 - Dietary Lutein Reduces Ultraviolet Radiation-Induced Inflammation and Immunosuppression
Journal of Investigative Dermatology
2004 - Vasoactive Intestinal Peptide Modulates Langerhans Cell Immune Function
The Journal of Immunology
2004 - Pituitary adenylate cyclase‐activating polypeptide inhibits cutaneous immune function
European Journal of Immunology
2003
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Toto, MD
The University of Texas Southwestern Medical Center
Margaret Pearle, MD, PhD
The University of Texas Southwestern Medical Center
George Buchanan, MD
The University of Texas Southwestern Medical Center
Vitaly Margulis, MD
The University of Texas Southwestern Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”